Corbalá Fuentes C, Pacheco Ureña A, Pedraza Ibarra S, Gárate Ureña J A, Manzano Miranda L, Carrillo Camacho A, Haro García L
Hospital General de Zona No. 3., IMSS, Mazatlán, Sinaloa.
Arch Inst Cardiol Mex. 1997 May-Jun;67(3):227-30.
To study propanthelin bromide efficacy in preventing vasovagal syncope relapse.
HGZ No. 3 IMSS, Mazatlán, Sinaloa, México, from 1992 to 1995.
10 patients with vasovagal syncope were selected from 41 syncope patients.
Prospective longitudinal.
clinical charts, neurologic and cardiologic evaluation, electrocardiogram, electroencephalogram, C.A.T., Holter, stress test and chest X rays were made. In 10 patients, 15 to 30 mg of propanthelin bromide thrice a day were administered, 12 month survey on was made measured.
Of the 10 patients, 7 were women mean age 18 years. In 9 of them no recurrence was evident abandoned 1 treatment, 4 had side effects.
Propanthelin bromide decreases vasovagal syncope episodes with few side effects.
研究溴丙胺太林预防血管迷走性晕厥复发的疗效。
1992年至1995年期间,墨西哥锡那罗亚州马萨特兰市社会保障局第三综合医院。
从41例晕厥患者中选出10例血管迷走性晕厥患者。
前瞻性纵向研究。
进行临床病历、神经和心脏评估、心电图、脑电图、计算机断层扫描、动态心电图监测、压力测试和胸部X光检查。对10例患者每日三次给予15至30毫克溴丙胺太林,并进行为期12个月的调查。
10例患者中,7例为女性,平均年龄18岁。其中9例无明显复发,1例放弃治疗,4例有副作用。
溴丙胺太林可减少血管迷走性晕厥发作,副作用较少。